Findings Indicate that Copper Products Remain Essential to U.S. Economy and National Security as Trump Administration Seeks to Protect and Enhance Industry
CPA welcomes the launch of a cross-agency Department of Justice and Department of Homeland Security Trade Fraud Task Force, aimed at bringing robust enforcement against importers and other parties who seek to defraud the United States.
The findings refute claims by the pharmaceutical lobby that tariffs would harm consumers, and instead underscore the urgent need for strong trade measures to reshore U.S. production of essential medicines.
The Congressional Budget Office (CBO) upped the ante on their estimate for fiscal deficit reduction last week, all due to higher tariffs that kicked into effect this month. Tariffs are offsetting tax cuts signed into law this summer in the One Big Beautiful Bill (OBBB).
America is dangerously reliant on high-risk foreign suppliers for essential generic drugs, especially APIs concentrated in China and India. That over-reliance has already triggered preventable crises, such as nationwide chemotherapy shortages when a single overseas plant shut down.
The study details how Beijing is pursuing a program of “space sector capture” to penetrate and control the space sectors of more than 120 countries through agreements with ostensibly private Chinese companies that, in effect, act as fronts for the People’s Liberation Army (PLA).
It’s been three full months of record-high tariffs, and yet rolling 12-month overall inflation came in at 2.7% in July, the same percentage rate as June, according to last week’s Bureau of Labor Statistics (BLS) inflation report. Core inflation (CPI), which excludes food and oil, rose 3.1% in July, up from 2.9% in June.
The inclusion of these steel products in the Section 232 tariff program will mean more jobs, more Made-in-the-USA, and help provide steady-order volume to our primary steel producers.